Publicaciones en colaboración con investigadores/as de Universidad de Cantabria (16)

2023

  1. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 837-847

  2. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. Genetic Basis of Vasculitides with Neurologic Involvement

    Neurologic Clinics, Vol. 37, Núm. 2, pp. 219-234

  3. Giant Cell Arteritis

    Rare Diseases of the Immune System (Springer Nature), pp. 129-149

2018

  1. Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 589-595

  2. Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review

    Autoimmunity Reviews, Vol. 17, Núm. 3, pp. 301-315

2017

  1. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis /692/699/1670 /692/4023/1670/595 article

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients

    PLoS ONE, Vol. 10, Núm. 11

2011

  1. Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 5, pp. 889-892

  2. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis

    Atherosclerosis, Vol. 216, Núm. 1, pp. 125-130

2010

  1. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1, pp. 68-72

  2. Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 5, pp. 695-701

  3. Reply

    Clinical and Experimental Rheumatology

2009

  1. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovasular events in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 1, pp. 116-119

  2. Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 6, pp. 964-970